Clinical Trial

Mental Strategy Training in Mild Cognitive Impairment

Completed
View on ClinicalTrials.gov →
Summary
This study aims to reduce hippocampal activity in people at high risk of developing Alzheimer's disease (AD) and aims to examine whether this improves their episodic memory performance. We apply mental strategy trainings with strategies extracted from our previous study that applied real-time fMRI neurofeedback to reduce hippocampal activity. Participants take part in mental strategy trainings 2, 4, or 6 times. At baseline and after each 2 trainings, we assess their hippocampal activity as well as their episodic memory performance using an fMRI pattern separation task. In addition, we will gather blood samples to obtain Apolipoprotein E gene status (ApoE, only once) as well as plasma pTau (pTau217; 4 time-points). ApoE will be included as a covariate in our statistical models. For pTau217, we will calculate the change between each assessment to examine whether the mental strategy training will change the accumulation of pTau217.
Trial Details
NCT Number NCT07718945
Lead Sponsor Jessica Peter
Conditions Mild Cognitive Impairment (MCI) Amnestic, Mild Cognitive Impairment
Enrollment 55 participants
Start Date 2024-02-13
Primary Completion 2025-10-22 (estimated)
Study Completion 2025-10-22 (estimated)
Updated on ClinicalTrials.gov 2026-07-22